News
-
TGA under pressure
Thursday | Apr 27 2017WITH the number of GMP Clearance Applications more than doubling from approximately 2,500 in 2010-2011 to more than 5,600 in 2015-2016, the Therapeutic Goods Administration (TGA) has struggled to manage its target timeframe of 15 days per application.
-
Winter spotlight
Thursday | Apr 27 2017SUPPLIERS can cost-effectively showcase their wares in Pharmacy Daily's upcoming Winter Spotlight feature, which kicks off next week.
-
Labelling standards
Thursday | Apr 27 2017A new study published by the BMJ last week has found using standardised medicine packaging could improve efficiencies while still maintaining safety.
-
Novartis HRT short
Thursday | Apr 27 2017NOVARTIS has confirmed that supplies of hormone replacement therapy patches continue to be unreliable due to manufacturing issues, with the company anticipating a return to stable supply of items such as Estradot and Estalis by the middle of 2017.
-
PBAC agenda out
Thursday | Apr 27 2017THE Health Department has released the agenda for the Jul 2017 Pharmaceutical Benefits Advisory Committee meeting, which will consider a whopping 60-plus submissions and reports.
-
JPPR edition out
Thursday | Apr 27 2017THE newest edition of the Society of Hospital Pharmacists of Australia Journal of Pharmacy Practice and Research (JPPR) is now available online, with the publication including details of the first Australian case report into the side effects of nivolumab, used to treat inoperable or metastatic melanoma.
-
New dermatitis course
Thursday | Apr 27 2017GUILD Learning and Development has announced that, in partnership with skincare specialist company Ego Pharmaceuticals, it has developed a new online training module, "Quality use of topical corticosteroids in atopic dermatitis".
-
Antizol approval
Thursday | Apr 27 2017ANTIZOL (fomepizol) has received regulatory approval in Australia and is now available for the treatment of methanol and ethylene glycol toxicities.